Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chonglian Oral Liquid (Anhui University of Chinese Medicine)
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Anhui University of Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Chonglian Oral Liquid (also known as Chonglian or Zhonglian Oral Liquid) is a traditional Chinese medicine (TCM) hospital preparation developed by the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine. Formulated based on Xinan medicine principles, it is composed of seven herbal ingredients: Paris polyphylla (Rhizoma Paridis), Isatis tinctoria leaf (Folium Isatidis), Isatis tinctoria root (Radix Isatidis), Scutellaria baicalensis (Radix Scutellariae), Belamcanda chinensis (Rhizoma Belamcandae), Forsythia suspensa (Fructus Forsythiae), and Glycyrrhiza uralensis (Radix Glycyrrhizae). Chonglian Oral Liquid exerts heat-clearing, detoxifying, throat-soothing, and cough-relieving effects. It is primarily approved as a hospital preparation in Anhui Province, China, for the treatment of acute upper respiratory tract infections (wind-fever pattern) and has been clinically evaluated for the treatment of influenza and COVID-19.
- Other names
- Chonglian重连口服液
02
Targets
MAPK14 (p38 mitogen-activated protein kinase alpha)RELA (Nuclear Factor Kappa B Subunit p65)
Beyond the preview
Go deeper on Chonglian Oral Liquid (Anhui University of Chinese Medicine).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chonglian Oral Liquid (Anhui University of Chinese Medicine).